2-{[(1-methyl-1H-imidazol-2-yl)methyl]amino}ethanol dihydrochloride, 95.0%, 1g

3-Oxetaneacetic acid, 95.0%, 250mg

1-Quinoxalin-2-yl-butane-1,2,3,4-tetraol, 95.0%, 5g

2,2,2-TRIFLUORO-1-(M-TOLYL)ETHANOL, 95.0%, 1g

6-bromo-7-methoxy-2-methyl-1H,4H-pyrido[2,3-d]pyrimidin-4-one, 98%, 500mg

ISOBUTYLHYDRAZINE, 95.0%, 1g

tert-butyl 4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1-carboxylate, 1g

METHYL 4-(METHOXYMETHYL)BENZOATE, 95.0%, 1g

2-hydrazino-1-(3-methylbutyl)-1H-benzimidazole hydrochloride hydrate, 95.0%, 10g

n-Hexadecyltriethoxysilane, 92%, 25g

TRANS11-TETRADECENAL, 95.0%, 5g

1-(Pyridin-3-ylmethyl)-1H-imidazole-4-carboxylic acid, 1g

3-nitroaniline, min. 99%, for synthesis, 500 g, plastic packaging.